MUC1 and pancreatic neoplasm: Furthermore, bioinformatics and molecular biology techniques were integrated to validate the expression pattern of MUC1 in pancreatic cancer and its clinical relevance, thereby providing a theoretical foundation for the targeted design of the DC vaccine.